Literature DB >> 20606591

Anatomical study of forehead flap with its pedicle based on cutaneous branch of supratrochlear artery and its application in nasal reconstruction.

Dong Yu1, Rui Weng, Huiyong Wang, Xiongzheng Mu, Qingfeng Li.   

Abstract

This study was conducted to investigate whether there is a consistent cutaneous branch by anatomic research of the supratrochlear artery. Ten fresh adult cadavers were selected. Anastomosis between the supratrochlear artery and supraorbital artery was observed. The mean distance from the supraorbital rim to the supratrochlear artery was 1.18 +/- 0.36 cm. A consistent cutaneous branch of the supratrochlear artery increased in a position 1.35 +/- 0.34 cm lateral to the midline that anastomosed abundantly with the cutaneous branch, the muscular branch of the opposite side, the ipsilateral muscular branch, and bilateral supraorbital arteries. An ultrathin forehead skin flap with the cutaneous branch as the blood vessel was designed and used for nasal reconstruction in 15 cases. Postoperatively, all flaps survived successfully with satisfactory surgical results. The advantages of the flap are its thin feature and preservation of the entirety of the frontalis muscle.

Entities:  

Mesh:

Year:  2010        PMID: 20606591     DOI: 10.1097/SAP.0b013e3181c1fee3

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  2 in total

1.  Fascia Lata Free Flap Anastomosed to the Superior Trochlear System for Reconstruction of the Anterior Skull Base.

Authors:  Camilo Reyes; C Arturo Solares; Michael A Fritz; Michael Groves; Heather Bentley
Journal:  J Neurol Surg B Skull Base       Date:  2017-05-08

Review 2.  Effectiveness of Nasolabial Flap Versus Paramedian Forehead Flap for Nasal Reconstruction: A Systematic Review and Meta-analysis.

Authors:  Sourabh Shankar Chakraborty; Akhil Dhanesh Goel; Ranjit Kumar Sahu; Manojit Midya; Sudeshna Acharya; Neha Shakrawal
Journal:  Aesthetic Plast Surg       Date:  2022-09-14       Impact factor: 2.708

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.